000 | 01636 a2200433 4500 | ||
---|---|---|---|
005 | 20250517105221.0 | ||
264 | 0 | _c20170726 | |
008 | 201707s 0 0 eng d | ||
022 | _a1872-6240 | ||
024 | 7 |
_a10.1016/j.brainres.2016.07.026 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aWatson, Christopher P | |
245 | 0 | 0 |
_aThe transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro. _h[electronic resource] |
260 |
_bBrain research _c10 2016 |
||
300 |
_a232-242 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aArginine _xanalogs & derivatives |
650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
650 | 0 | 4 |
_aCationic Amino Acid Transporter 1 _xmetabolism |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aCell Survival _xdrug effects |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aInterferon-gamma _xpharmacology |
650 | 0 | 4 |
_aNitric Oxide _xmetabolism |
650 | 0 | 4 |
_aOrnithine _xanalogs & derivatives |
650 | 0 | 4 | _aPermeability |
650 | 0 | 4 |
_aReactive Oxygen Species _xmetabolism |
650 | 0 | 4 |
_aSucrose _xmetabolism |
650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xpharmacology |
700 | 1 | _aPazarentzos, Evangelos | |
700 | 1 | _aFidanboylu, Mehmet | |
700 | 1 | _aPadilla, Beatriz | |
700 | 1 | _aBrown, Rachel | |
700 | 1 | _aThomas, Sarah A | |
773 | 0 |
_tBrain research _gvol. 1648 _gno. Pt A _gp. 232-242 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.brainres.2016.07.026 _zAvailable from publisher's website |
999 |
_c26240829 _d26240829 |